These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody. Tanaka M; Tanaka K; Shinozawa K; Idezuka J; Tsuji S J Neurol Sci; 1998 Nov; 161(1):88-90. PubMed ID: 9879687 [TBL] [Abstract][Full Text] [Related]
7. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice. Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964 [TBL] [Abstract][Full Text] [Related]
9. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss. Tanaka M; Tanaka K; Onodera O; Tsuji S Clin Neurol Neurosurg; 1995 Feb; 97(1):95-100. PubMed ID: 7788981 [TBL] [Abstract][Full Text] [Related]
10. Association of anti-Yo (type I) antibody with paraneoplastic cerebellar degeneration in the setting of transitional cell carcinoma of the bladder: detection of Yo antigen in tumor tissue and fall in antibody titers following tumor removal. Greenlee JE; Dalmau J; Lyons T; Clawson S; Smith RH; Pirch HR Ann Neurol; 1999 Jun; 45(6):805-9. PubMed ID: 10360776 [TBL] [Abstract][Full Text] [Related]
11. Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody. Tanaka M; Tanaka K; Idezuka J; Tsuji S Exp Neurol; 1998 Apr; 150(2):337-8. PubMed ID: 9527904 [TBL] [Abstract][Full Text] [Related]
12. Neuronal calcium channel autoantibodies coexisting with type 1 Purkinje cell cytoplasmic autoantibodies (PCA-1 or "anti-Yo"). Lennon VA; Kryzer TJ Neurology; 1998 Jul; 51(1):327-9. PubMed ID: 9674845 [No Abstract] [Full Text] [Related]
15. Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus. Sutton IJ; Fursdon Davis CJ; Esiri MM; Hughes S; Amyes ER; Vincent A Ann Neurol; 2001 Feb; 49(2):253-7. PubMed ID: 11220746 [TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease. Hammack J; Kotanides H; Rosenblum MK; Posner JB Neurology; 1992 Oct; 42(10):1938-43. PubMed ID: 1407576 [TBL] [Abstract][Full Text] [Related]
17. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of unknown origin. Krakauer J; Balmaceda C; Gluck JT; Posner JB; Fetell MR; Dalmau J Neurology; 1996 May; 46(5):1486-7. PubMed ID: 8628511 [No Abstract] [Full Text] [Related]
18. HLA antigens in paraneoplastic cerebellar degeneration associated with anti-Yo antibody. Tanaka M; Tanaka K; Tsuji S Neurodegeneration; 1994 Dec; 3(4):341-2. PubMed ID: 7842305 [No Abstract] [Full Text] [Related]
19. Cytotoxic T cell activity against the peptide, AYRARALEL, from Yo protein of patients with the HLA A24 or B27 supertype and paraneoplastic cerebellar degeneration. Tanaka M; Tanaka K; Tsuji S; Kawata A; Kojima S; Kurokawa T; Kira J; Takiguchi M J Neurol Sci; 2001 Jul; 188(1-2):61-5. PubMed ID: 11489286 [TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic antibodies detected by isoelectric focusing of cerebrospinal fluid and serum. Storstein A; Monstad SE; Honnorat J; Vedeler CA J Neuroimmunol; 2004 Oct; 155(1-2):150-4. PubMed ID: 15342206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]